Ovid Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 67
Employees
  • Stock Symbol
  • OVID
Stock Symbol
  • Share Price
  • $3.37
  • (As of Monday Closing)

Ovid Therapeutics General Information

Description

Ovid Therapeutics Inc is a US based biopharmaceutical company. The firm is primarily engaged in developing impactful medicines for patients and families living who are suffering with rare neurological disorders. It is targeting disorders such as intellectual disability, severe speech impairment, problems with movement and balance, sleep disorders and anxiety to transform the patient's life.

Contact Information

Website
www.ovidrx.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 1460 Broadway
  • Suite 15021
  • New York, NY 10036
  • United States
+1 (646) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ovid Therapeutics Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.37 $3.48 $2.25 - $9.40 $228M 67.8M 3.59M -$1.39

Ovid Therapeutics Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 59,669 59,669 160,530 7,155
Revenue 12,617 12,617 0 0
EBITDA (80,729) (80,729) (60,206) (52,790)
Net Income (81,036) (81,036) (60,461) (51,980)
Total Assets 75,926 75,926 80,844 47,650
Total Debt 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ovid Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ovid Therapeutics‘s full profile, request access.

Request a free trial

Ovid Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Ovid Therapeutics‘s full profile, request access.

Request a free trial

Ovid Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Ovid Therapeutics Inc is a US based biopharmaceutical company. The firm is primarily engaged in developing impactful med
Drug Discovery
New York, NY
67 As of 2020
00000
000000000 00000

000000 0

lor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint
0000 000000000
San Diego, CA
00 As of 0000
00000
0.00 0000-00-00
000000&0 00000

00000000

olor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint
0000 000000000
Clarksville, MD
0 As of 0000
00.000
000000 0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ovid Therapeutics Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Auspex Pharmaceuticals Formerly VC-backed San Diego, CA 00 00000 000000&0 00000
000000000000 Venture Capital-Backed Clarksville, MD 0 00.000 000000 0
0000000 Venture Capital-Backed San Carlos, CA 00 000.00 00000 00000 000.00
00000000 000000000 Formerly VC-backed Coral Gables, FL 00 000.00 00000000 000.00
0000000 0000000000 Venture Capital-Backed South San Francisco, CA 00 000.00 00000000000 000.00
You’re viewing 5 of 10 competitors. Get the full list »

Ovid Therapeutics Executive Team (16)

Name Title Board Seat Contact Info
Jeremy Levin Ph.D Chief Executive Officer & Chairman
Amit Rakhit MD Chief Medical Officer & President
Timothy Daly Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Dirk Haasner Ph.D Senior Vice President
Suzanne Wakamoto Senior Vice President, Human Resources
You’re viewing 5 of 16 executive team members. Get the full list »

Ovid Therapeutics Board Members (6)

Name Representing Role Since
Bart Friedman JD Self Board Member 000 0000
Douglas Williams Ph.D Self Board Member 000 0000
Jeremy Levin Ph.D Ovid Therapeutics Chief Executive Officer & Chairman 000 0000
Karen Bernstein Ph.D Self Board Member 000 0000
You’re viewing 4 of 6 board members. Get the full list »

Ovid Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial